MSI Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$7.01M Sell
79,203
-3,003
-4% -$273K 0.23% 104
2016
Q3
$7.93M Buy
82,206
+927
+1% +$88.2K 0.27% 86
2016
Q2
$6.97M Sell
81,279
-17,802
-18% -$1.6M 0.25% 92
2016
Q1
$8.61M Sell
99,081
-47,085
-32% -$4.21M 0.36% 58
2015
Q4
$16.5M Buy
146,166
+74,238
+103% +$8.06M 0.75% 20
2015
Q3
$7.27M Sell
71,928
-16,152
-18% -$1.94M 0.57% 28
2015
Q2
$10.8M Buy
88,080
+29,970
+52% +$3.59M 0.77% 19
2015
Q1
$6.65M Buy
58,110
+19,911
+52% +$2.2M 0.47% 39
2014
Q4
$3.86M Buy
38,199
+2,091
+6% +$203K 0.42% 49
2014
Q3
$3.29M Buy
36,108
+2,079
+6% +$182K 0.4% 49
2014
Q2
$2.92M Sell
34,029
-15,798
-32% -$1.24M 0.39% 53
2014
Q1
$3.93M Buy
49,827
+1,920
+4% +$160K 0.56% 29
2013
Q4
$3.63M Buy
47,907
+8,568
+22% +$608K 0.55% 32
2013
Q3
$2.75M Buy
39,339
+6,651
+20% +$436K 0.48% 42
2013
Q2
$1.9M Buy
+32,688
New +$1.89M 0.38% 57

Other funds holding IBB

MSI Financial Services's IBB Position: Q4 2016 in Review

MSI Financial Services reduced its iShares Biotechnology ETF (IBB) stake by 3.7% in Q4 2016, selling an estimated $273K and leaving 79,203 shares worth $7.01M. The position accounts for 0.23% of the portfolio, ranked #104.

MSI Financial Services first reported a position in IBB in Q2 2013 and has held it in 15 quarters since. The position peaked at $16.5M in Q4 2015. 522 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

  • MSI Financial Services held 79,203 shares of iShares Biotechnology ETF worth $7.01M as of Q4 2016.
  • MSI Financial Services sold 3,003 iShares Biotechnology ETF shares in Q4 2016, an estimated $273K.
  • iShares Biotechnology ETF made up 0.23% of MSI Financial Services's portfolio in Q4 2016, its #104 holding.
  • MSI Financial Services first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's iShares Biotechnology ETF position peaked at $16.5M in Q4 2015.
  • 522 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.